HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes

Journal of Clinical Investigation

Volumn 102, Issue 4, 1998, Pages 804-812

  Ueda, Hirotsugu ^a   Howard, O M Zack ^a   Grimm, Michael C ^a   Su, Shao Bo ^a   Gong, Wanghua ^a   Evans, Gerald ^a   Ruscetti, Francis W ^a   Oppenheim, Joost J ^a   Wang, Ji Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemokines; gp41; HIV 1; Receptors; Suppression

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 41; PROTEIN KINASE C INHIBITOR;

ARTICLE; CALCIUM TRANSPORT; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; VIRUS CELL INTERACTION;

EID: 0032529035     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3273     Document Type: Article

References (50)

1. Willey, R.L., J.S. Bonifacino, B.J. Potts, M.A. Martin, and R.D. Klausner. 1988. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA. 85: 9580-9584.
2. Freed, E.O., and M.A. Martin. 1995. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J. Biol. Chem. 270: 23883-23886.
3. Klatzmann, D., E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J.C. Gluckman, and L. Montagnier. 1984. T-lymphocyte T4 molecule behaves as the receptor for human rctrovirus LAV. Nature. 312:767-768.
4. Dalgleish, A.G., P.C.L. Beverley, P.R. Clapham, D.H. Crawford, M.F. Greaves, and R.A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:763-767.
5. Moore, J.P., and A. Trokula. 1997. HIV type 1 coreceptors, neutralization serotypes, and vaccine development. AIDS Res. Hum. Retroviruses. 13: 733-736.
6. Chan, D.C., D. Pass, J.M. Berger, and P.S. Kim. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:263-273.
7. Stein, B., S. Gowda, J. Lifson, R. Penhallow, K. Bensch, and E. Engelmann. 1987. pH independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell. 50:327-328.
8. Freed, E.O., D.J. Myers, and R. Risser. 1990. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA. 87:4650-1654.
9. Smith, P.D., K. Ohura, H. Masur, H.C. Lane, A.S. Fauci, and S.M. Wahl. 1984. Monocyte function in the acquired immune deficiency syndrome. J. Clin. Invest. 74:2121-2128.
10. Wahl, S.M., J.B. Allen, S. Gartner, J.M. Orenstein, M. Opovic, D.E. Chenoweth, L.O. Arthur, W.L. Farrar, and L.M.J. Wahl. 1989. HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemolactic function of peripheral blood monocytes. J. Immunol. 142:3553-3559.
11. Koka, P., K. He, J.A. Zack, S. Kitchen, W. Peacock, I. Fried, T. Tran, S. Yashar, and J.E. Merrill. 1995. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor α, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J. Exp. Med. 182: 941-952.
12. Merrill, J.E., V. Koyanagi, J. Zack, L. Thomas, F. Martin, and I.S.Y. Chen. 1992. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures with human immunodeficiency virus type 1. J. Virol. 66:2217-2225.
13. Koka, P., K. He, D. Camerini, T. Tran, S.S. Yashar, and J.E. Merrill. 1995. The mapping of HIV-1 gp160 epitopes required for IL-1 and TNFα production in glial cells. J. Neuroimmunol. 57:179-191.
14. Merrill, J.E., and O. Martinez-Maza. 1993. Cytokines in AIDS-associated neurons and immune system dysfunction. In Neurobiology of Cytokines. Part B: Methods in Neuroscience. De Souza, E.B., editor. Academic Press, Inc., San Diego, CA. 243-266.
15. Takeshita, S., E.C. Breen, M. Ivashchenko, P.G. Nishanian, T. Kishimoto, D.L. Vredevoe, and O. Martinez-Maza. 1995. Induction of IL-6 and IL-10 production by recombinant HIV-1 envelope glycoprotein 41 (gp41) in the THP-1 human monocytic cell line. Cell. Immunol. 165:234-242.
16. Adamson, D.C., B. Wildemann, M. Sasaki, J.D. Glass, J.C. McArthur, V.I. Christov, T.M. Dawson, and V.L. Dawson. 1996. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science. 274:1917-1921.
17. Chen, Y.-H., A. Christiansen, and M.P. Dierich. 1995. HIV-1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen-and recall antigen-induced lymphocyte proliferation. Immunol. Lett. 48:39-44.
18. Koutsonikolis, A., S. Haraguchi, E.N. Brigino, U.E. Owens, R.A. Good, and N.K. Day. 1997. HIV-1 recombinant gp41 induces IL-10 expression and production in peripheral blood monocytes but not in T-lymphocytes. Immunol. Lett. 55:109-113.
19. Haraguchi, S., R.A. Good, M. James-Yarish, G.J. Cianciolo, and N. Day. 1995. Differential modulation of Th1-and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc. Natl. Acad. Sci. USA. 92:3611-3615.
20. Haraguchi, S., R.A. Good, G.J. Cianciolo, R.W. Engelman, and N.K. Day. 1997. Immunosuppressive retroviral peptides: immunological implications for immunosuppressive influence of retroviral infections. J. Leukocyte Biol. 61: 654-666.
21. Baggiolini, M., B. Deward, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:97-178.
22. Oppenheim, J.J., J.M. Wang, O. Chertov, D.D. Taub, and A. Ben-Baruch. 1996. The role of chemokines in transplantation biology. In Cellular and Molecular Aspects. N.L. Tilney, T.B. Strom, and L.C. Paul, editors. Philadelphia. Lippincott-Raven. 182-200.
23. Xu, L.L., D.W. McVicar, A. Ben-Baruch, D.B. Kuhns, J. Johnston, J.J. Oppenheim, and J.M. Wang. 1995. Monocyte chemotactic protein-3 (MCP-3) interacts with multiple leukocyte receptors: binding and signaling of MCP-3 through shared as well as unique receptors on monocytes and neutrophils. Eur. J. Immunol. 25:2612-2617.
24. Ben-Baruch, A., L. Xu, P.R. Young, K. Bengali, J.J. Oppenheim, and J.M. Wang. 1995. Monocyte chemotactic protein-3 (MCP-3) interacts with multiple leukocyte receptors. C-C CKR1, a receptor for macrophage inflammatory protein-1α/RANTES, is also a functional receptor for MCP3. J. Biol. Chem. 270:22123-22128.
25. Combadiere, C., S.K. Ahuja, H.L. Tiffany, and P.M. Murphy. 1996. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1α. MIP-1β and RANTES. J. Leukocyte Biol. 60:147-152.
26. Samson, M., O. Labbe, C. Mollerau, G. Vassart, and M. Parmentier. 1996. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry. 35:3362-3367.
27. Raport, C.J., J. Gosling, V.L. Schweickart, P.W. Gray, and I.F. Charo. 1996. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES. MIP-1β and MIP-1α. J. Biol. Chem. 271:17161-17166.
28. Neote. K., D. DiGregorio, J.Y. Mak, R. Horuk, and T.J. Schall. 1993. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell. 72:415-425.
29. Gao, J.L., D.B. Kuhns, H.L. Tiffany, D. McDermot, X. Li, U. Francke, and P.M. Murphy. 1993. Structure and functional expression of the human macrophage inflammatory protein 1α/RANTES receptor. J. Exp. Med. 177:1421-1427.
30. Franci, C., L.M. Wong, J. Van Damme, P. Proost, and I.F. Charo. 1995. Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the the human monocyte chemoattractant protein-1 receptor. J. Immunol. 154:6511-6517.
31. Combadiere, C., S.K. Ahuja, J. Van Damme, H.L. Tiffani, J.-L. Gao, and P.M. Murphy. 1995. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J. Biol. Chem. 270:29671-29675.
32. Golding, H., J. Manischewitz, L. Vujcic, R. Blumenthal, and D.S. Dimitrov. 1994. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component (s) in CD4-expressing cells. J. Virol. 68:1962-1969.
33. Quresshi, N.M., D.H. Coy, R.F. Garry, and L.A Henderson. 1990. Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. AIDS. 4:553-558.
34. Chen, Y.-H., C. Ebenbichler, R. Vornhagen, T.F. Schulz, F. Steindl, G. Buck, H. Katinger, and M.P. Dierich. 1992. HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line. H9. AIDS. 6:533-539.
35. Chen, Y.-H., and M.P. Dierich. 1996. Identification of a second site in HIV-1 gp41 mediating binding to cells. Immunol. Lett. 52:153-156.
36. Ebenbichler, C.F., H. Stoiber, R. Schneider, J.R. Patsch, and M.P. Dierich. 1996. The human immunodeficiency virus type 1 transmembrane gp41 protein is a calcium-binding protein and interacts with the putative second-receptor molecules in a calcium-dependent manner. J. Virol. 70:1723-1728.
37. Ugolini, S., M. Moulard, I. Mondor, N. Barois, D. Demandolx, J. Hoxie, A. Brelot, M. Alizon, J. Davoust, and Q.J. Sattentau. 1997. HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4. J. Immunol. 159:3000-3008.
38. Demaria, S., and Y. Bushkin, 1996. Soluble CD4 induces the binding of human immunodeficiency virus type 1 to cells via the V3 loop of glycoprotein 120 and specific sites in glycoprotein 41. AIDS Res. Hum. Retroviruses. 12:281-290.
39. Ravichandran, K.S., T.L. Collins, and S.J. Burakoff. 1996. CD4 and signal transduction. Curr. Top. Microbiol. Immunol. 205:47-62.
40. D'Oro, U., M.S. Vacchio, A.M. Weissman, and J.D. Ashwell. 1997. Activation of the Lck tyrosine kinase targets cell surface T cell antigen receptors for lysosomal degradation. Immunity. 7:619-628.
41. Center, D.M., H. Kornfeld, and W.W. Cruikshank. 1996. Interleukin 16 and its function as a CD4 ligand. Immunol. Today. 17:476-481.
42. Weissman, D., R.L. Rabin, J. Arthos, A. Rubbert, M. Dybul, R. Swofford, S. Venkatesan, J.M. Farber, and A.S. Fauci. 1997. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature. 389:981-985.
43. Davis, C.B., I. Dikic, D. Unutmaz, C.M. Hill, J. Arthos, M.A. Siani, D.A. Thompson, J. Schlessinger, and D.R. Littman. 1997. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 186:1793-1748.
44. Richardson, R.M., H. Ali, E.D. Tomnave, B. Haribabu, and R. Snyderman. 1995. Cross-desensitization of chemoattractant receptors occurs at multiple levels. J. Biol. Chem. 270:27829-27833.
45. Parada, N.A., W.W. Cruikshank, H.L. Danis, T.C. Ryan, and D.M. Center. 1996. IL-16-and other CD4 ligand-induced migration is dependent upon protein kinase C. Cell. Immunol. 168:100-106.
46. Wahl, L.M., M.L. Corcoran, S.W. Pyle, L.O. Arthur, A. Harel-Bellan, and W.L. Farrar. 1989. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc. Natl. Acad. Sci. USA. 86:621-625.
47. Lapham, C.K., J. Ouyang, B. Chandrasekhar, N.Y. Nguyen, D.S. Dimitrov, and H. Golding. 1996. Evidence for cell-surface association between fusin and the CD4/gp120 complex in human cell lines. Science. 274:602-605.
48. 4 signal-dependent chemokine receptor down-regulation. J. Immunol. In press.
49. Nara, P.L., R.R. Garrity, and J. Goldsmith. 1991. Neutralization of HIV: a paradox of humoral proportions. FASEB (Fed. Am. Soc. Exp. Biol.) J. 5:2437-2455.
50. Wild, C.T., D.C. Shgars, T.K. Greenwell, C.B. McDanal, and T.J. Mathews. 1994. Peptides corresponding to a predictive a-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA. 91:9770-9774.